Optometrists in Ambridge, PA Accepting Medicare
4 Optometrists found. Showing 1 - 4
 Howard I Cohen, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 644 Merchant St, Ambridge, PA 15003 Phone: 724-266-4477 Fax: 724-266-3464 |
 The Eye Center, Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 644 Merchant St, Ambridge, PA 15003 Phone: 724-266-4477 Fax: 724-266-3464 |
 Mrs. Alethea Athena Rivera-molina, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 644 Merchant St, Ambridge, PA 15003 Phone: 724-266-4477 Fax: 724-266-3464 |
Dr. Alejandro J Molina, OPTOMETRIST Optometrist Medicare: Accepting Medicare Assignments Practice Location: 644 Merchant St, Ambridge, PA 15003 Phone: 724-266-4477 Fax: 724-266-3464 |
News Archive
CSHL researcher-inventor hails FDA approval of new SMA drug
Within a week of Christmas day, a drug called nusinersen will be in the hands of doctors across the nation, who will use it, most urgently, to treat young children with a severe and potentially fatal illness called spinal muscular atrophy (SMA).
Major turning point in antiepileptic drug testing, development
New York University researchers revealed that data from previously completed withdrawal to monotherapy studies for antiepileptic drugs provide a valid control for future studies, obviating the need for placebo/pseudo-placebo trials to demonstrate the efficacy of these drugs as monotherapy. Results of this study are now available online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.
Prometheus, Tarrot announce exclusive agreement for Crohn's Disease treatment
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, and Tarrot Laboratories, a business unit of Cedars-Sinai Medical Center, today announced the execution of an exclusive research collaboration and license agreement. The collaboration will focus on identifying genetic or serologic markers associated with clinical responses to anti-TNF therapies such as Cimzia, Humira and Remicade utilized in the treatment of Crohn's Disease, and the subsequent development of diagnostic tests.
Researcher receives grant to find compounds that interrupt binding of cancer cells to blood vessels
In scary movies, the killer often comes back to life mysteriously, attacking again when the main character least expects it. Blood cancers are like this too, finding a safe spot to hide during treatment and then striking again when a patient is in remission.
› Verified 7 days ago
Podiatrists
Optometrists
Speech-Language Pathologists
Chiropractors
Physical Therapists
Occupational Therapists